Genetic Analysis of Uncommon Disease Presentations in Non-US Populations

Launched by NATIONAL HUMAN GENOME RESEARCH INSTITUTE (NHGRI) · Sep 18, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the genetic causes of rare and undiagnosed diseases, especially in children and families living outside the United States. Researchers want to use advanced genetic testing tools to find out if there are specific genes linked to unusual health conditions that have not yet been identified. The study aims to help these families by finding potential genetic explanations for their health issues.

To participate, children aged 2 to 18 years, along with their family members, should have a suspected genetic disease and live primarily outside the US. Participants will undergo a physical exam, answer questions about their health and family history, and provide samples like blood or saliva for genetic testing. Throughout the study, participants will be informed about any significant findings, including if a known genetic disease is identified or if any gene variants that could cause disease are discovered. This research could help uncover important insights into rare diseases and improve understanding for families affected by them.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• To be eligible to participate in this study, an individual must meet all of the following criteria:
• • 1. Stated willingness to comply with all study procedures and availability for the duration of the study.
• • 2. Probands aged \>2 years at enrollment or first-degree relatives of probands (age \>2 years).
• • 3. Suspicion of genetic etiology of illness due to strong family history, precocious onset, severity or mildness of phenotype, or all factors being present.
• • 4. Affected individuals and unaffected family members, determination of clinical criteria for inclusion will be determined by medical record review prior to participation.
• • 5. Ability of participant and their parent or guardian to understand and have willingness to sign a written informed consent and/or assent document.
• EXCLUSION CRITERIA:
• An individual who meets any of the following criteria will be excluded from participation in this study:
• • 1. Anyone unwilling to provide informed consent (for themselves as adults, on behalf of their children as minors, or on behalf of an adult who is unable to provide consent for themselves) or assent.
• • 2. Individuals who have undergone diagnostic testing for a genetic condition AND the test results were positive.
• • 3. Evidence that symptoms are secondary or caused by an undiagnosed condition that is unlikely to have a genetic cause.
• • 4. In the opinion of the investigator, participant has a condition that would preclude participation in the study by interfering with the participant s ability to engage in the required protocol evaluation and testing.